Administrative Core
行政核心
基本信息
- 批准号:10461121
- 负责人:
- 金额:$ 54.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-15 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdherenceAdvisory CommitteesAffectAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease riskAnimal WelfareAnnual ReportsAwardBehavioral ResearchBiological MarkersCaregiver researchCaringClinicalCognitiveCognitive agingCollaborationsCommunitiesDataData SetDementiaDevelopmentDiagnosisDiseaseEarly DiagnosisEnsureEnvironmentEpidemiologyFacultyFundingFunding AgencyFutureGeographyGoalsGrantGrowthHeterogeneityImageInfrastructureInternationalLeadershipLongevityMissionOutcomeParticipantPathologyPoliciesPopulation HeterogeneityProcessResearchResearch PersonnelResearch Project GrantsResearch TrainingResourcesRiskRisk FactorsSamplingScienceScientistSerumStrategic PlanningTimeTrainingTraining ProgramsUnited States National Institutes of HealthVisionWorkaging braincaregivingcollaborative environmentcommunity based researchcomplement resourcedata exchangeethnic minorityflexibilityhigh riskhuman subjectimprovedinnovationnext generationnoveloutreachpreventprogramsracial minority populationrecruitstudy populationsuccesstherapy developmenttreatment strategyundergraduate student
项目摘要
PROJECT SUMMARY/ABSTRACT - Administrative Core
The mission of the UC Davis Alzheimer’s Disease Research Center (UCD ADRC) is to advance the science of
healthy brain aging while caring for those affected by dementia. To accomplish this mission, we have
created a highly integrated and collaborative environment with extensive resources to support studies
on the heterogeneity of cognitive aging and progression to dementia among diverse populations. The
Administrative Core (AC) supports this mission through overall direction and optimal utilization of center
resources with emphasis on strategies that encompass 1) development of new research initiatives, 2)
leveraging available resources through integration of research effort and pursuit of research funding, 3)
program growth through local, national and international collaborations and initiation of new programs, and,
finally, 4) pursuit of funding sources for training of junior scientists so as to expand and provide continuity for
our program of research on aging and ADRD. Our approach addresses a number of milestones set by the
National Alzheimer’s Project Act by 1) evaluating disparities among ethnic and racial minority populations that
are at higher risk for AD to mitigate risk and improve cognitive outcomes, 2) fully characterizing mixed
pathologies and identifying unique risk factors,3) accelerating the development of treatments that would
prevent, halt, or reverse the course of Alzheimer’s disease (AD), 4) improving early diagnosis through
discovery of novel imaging and serum biomarkers, 5) developing novel dementia treatment strategies, and 6)
supporting caregiving through funded caregiver research. The AC also has a long tradition of supporting the
overall NIA ADC Network to achieve NAPA goals “…through increasing flexibility and collaboration by
leveraging resources, capabilities and research participants across the network”. Consistent with our overall
approach, the AC also has historically contributed to efforts to “…unify goals, ensure that resources are most
efficiently utilized, and is suitably flexible to facilitate the ability of the ADC network to respond to a dynamic
scientific environment while incorporating the needs of all stakeholders…” As such, the AC provides
outstanding leadership along with the infrastructure and the administrative support needed to meld the various
Cores and geographically dispersed units of the UCD ADRC into a true, coherent and effective research
center. Specifically, the AC will direct and strategically plan to utilize the full complement of resources and
expertise of the UCD ADRC, incorporating the developmental projects, our community based research
approach and extensive research training program to fulfill the milestones of NAPA.
项目概要/摘要-行政核心
加州大学戴维斯分校阿尔茨海默病研究中心(UCD ADRC)的使命是推进以下科学:
健康的大脑老化,同时照顾那些受痴呆症影响的人。为了完成这一使命,
创造了一个高度整合和协作的环境,拥有广泛的资源来支持研究
在不同人群中认知老化和痴呆症进展的异质性。的
行政核心(AC)通过全面指导和最佳利用中心来支持这一使命
资源,重点是战略,包括1)发展新的研究计划,2)
通过整合研究工作和寻求研究资金来利用现有资源,3)
通过地方、国家和国际合作以及新项目的启动,实现项目增长,
最后,4)寻求资金来源,培训年轻科学家,以扩大和提供连续性,
我们对衰老和ADRD的研究计划。我们的方法解决了一些里程碑设置的
国家阿尔茨海默病项目法案,1)评估少数民族和种族人口之间的差异,
AD的风险较高,以减轻风险并改善认知结果,2)完全表征混合
病理学和识别独特的风险因素,3)加速治疗的发展,
预防、停止或逆转阿尔茨海默病(AD)的进程,4)通过以下途径改善早期诊断:
发现新的成像和血清生物标志物,5)开发新的痴呆治疗策略,以及6)
通过资助看护者研究支持康复。AC也有支持的悠久传统,
国家评估方案发展援助网络总体实现国家适应行动方案目标“.通过增加灵活性和合作,
利用整个网络的资源、能力和研究参与者”。与我们的整体
在这种方法中,AC在历史上也为“......统一目标,确保资源最大化”的努力做出了贡献。
有效地利用,并且是适当灵活的,以促进ADC网络响应于动态特性的能力。
科学环境,同时考虑到所有利益攸关方的需求.”因此,AC提供了
杰出的领导能力沿着基础设施和行政支持,
核心和地理上分散的UCD ADRC单元变成一个真正的,连贯的和有效的研究
中心具体而言,咨询委员会将指导和战略规划,充分利用补充资源,
UCD ADRC的专业知识,结合发展项目,我们的社区研究
国家适应行动方案的里程碑。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Charles DeCarli其他文献
Charles DeCarli的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Charles DeCarli', 18)}}的其他基金
Do Atmospheric Ultrafine Particles Lodge in the Brain and Cause Cognitive Decline Leading to Alzheimer's Disease Related Dementias?
大气超细颗粒是否会滞留在大脑中并导致认知能力下降,从而导致阿尔茨海默病相关的痴呆症?
- 批准号:
10591354 - 财政年份:2022
- 资助金额:
$ 54.1万 - 项目类别:
Study of Latinos-Investigation of Neurocognitive Aging-Alzheimer's disease
拉丁裔研究-神经认知衰老-阿尔茨海默病的调查
- 批准号:
10629449 - 财政年份:2022
- 资助金额:
$ 54.1万 - 项目类别:
Study of Latinos-Investigation of Neurocognitive Aging-Alzheimer's disease
拉丁裔研究-神经认知衰老-阿尔茨海默病的调查
- 批准号:
10370841 - 财政年份:2022
- 资助金额:
$ 54.1万 - 项目类别:
Early and life course socioeconomic adversity and dementia risk in Hispanics/Latinos
西班牙裔/拉丁裔的早期和生命历程社会经济逆境和痴呆风险
- 批准号:
10445900 - 财政年份:2022
- 资助金额:
$ 54.1万 - 项目类别:
Early and life course socioeconomic adversity and dementia risk in Hispanic/Latinos
西班牙裔/拉丁裔的早期和生命历程社会经济逆境和痴呆风险
- 批准号:
10831329 - 财政年份:2022
- 资助金额:
$ 54.1万 - 项目类别:
UC Davis Alzheimer's Disease Research Center
加州大学戴维斯分校阿尔茨海默病研究中心
- 批准号:
10461120 - 财政年份:2021
- 资助金额:
$ 54.1万 - 项目类别:
UC Davis Alzheimer's Disease Research Center
加州大学戴维斯分校阿尔茨海默病研究中心
- 批准号:
10666428 - 财政年份:2021
- 资助金额:
$ 54.1万 - 项目类别:
相似海外基金
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
- 批准号:
10057526 - 财政年份:2023
- 资助金额:
$ 54.1万 - 项目类别:
Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
- 批准号:
490105 - 财政年份:2023
- 资助金额:
$ 54.1万 - 项目类别:
Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
- 批准号:
2325465 - 财政年份:2023
- 资助金额:
$ 54.1万 - 项目类别:
Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
- 批准号:
10821172 - 财政年份:2023
- 资助金额:
$ 54.1万 - 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 54.1万 - 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 54.1万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 54.1万 - 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 54.1万 - 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 54.1万 - 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
491109 - 财政年份:2023
- 资助金额:
$ 54.1万 - 项目类别:
Fellowship Programs














{{item.name}}会员




